Trial · NCT02982668

Optimizing Early Enteral Nutrition in Severe Stroke

NCT02982668, Not applicable, Terminated, Xijing Hospital

3 sourcestrials-2026-11-12-0.5.0

Cite this record

ConductScience Library. Optimizing Early Enteral Nutrition in Severe Stroke. Trials, record NCT02982668. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02982668

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title: Optimizing Early Enteral Nutrition in Severe Stroke
NCT number: NCT02982668
Status: Terminated
Phases: Not applicable
Enrollment: 306 participants, actual
Lead sponsor: Xijing Hospital
Conditions: Severe Stroke, Acute Stroke, Dysphagia
Interventions: Initial enteral feeding, metoclopramide or mosapride
First posted: 2016-12-05
Last updated: 2021-11-04

Source ClinicalTrials.gov

Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

List	Outcome	Time frame	Description
Primary	Rate of patients with death or major disability (modified Rankin scale score ≥3)	3 months after enrollment	modified Rankin scale score, with score ranging from 0 (normal) to 6 (death), was used to evaluate the functional outcomes after stroke.
Secondary	Mortality (rate of patients with death)	3 months after enrollment	Rate of patients with death
Secondary	The scores of National Institute of Health stroke scale	7 days after enrollment	National Institute of Health stroke scale, with scores ranging from 0 (normal function) to 42 (functional impairment)) was used to evaluate the impairment caused by a stroke.
Secondary	Glasgow Coma Scale	7 days after enrollment	Glasgow Coma Scale, with scores ranging from 3 (no response) to 15 (normal response), was used to grade the conscious state.
Secondary	modified Rankin scale	7 days after enrollment	modified Rankin scale score, with score ranging from 0 (normal) to 6 (death), was used to evaluate the functional outcomes after stroke.
Secondary	Barthel index	7 days after enrollment	The Barthel Index is a scale, with score ranging from 0 to 100 (normal), that measures disability or dependence in activities of daily living in stroke patients
Secondary	modified Rankin scale	3 months after enrollment	modified Rankin scale score, with score ranging from 0 (normal) to 6 (death), was used to evaluate the functional outcomes after stroke.
Secondary	Barthel index	3 months after enrollment	The Barthel Index is a scale, with score ranging from 0 to 100 (normal), that measures disability or dependence in activities of daily living in stroke patients
Secondary	The incidence of treatment intolerance	7 days after enrollment	The intolerance including gastric retention, diarrhea, constipation, gastrointestinal hemorrhage
Secondary	The incidence of serious adverse events	3 months after enrollment

1 to 10 of 11Source ClinicalTrials.gov

See all 11 registered outcomes

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers12

The papers the trial lists on ClinicalTrials.gov.

PMID	Listed as	Source
12750536	RESULT	PubMed
15733717	RESULT	PubMed
20130154	RESULT	PubMed
20971534	RESULT	PubMed
22307571	RESULT	PubMed
22673593	RESULT	PubMed
24289189	BACKGROUND	PubMed
26398094	RESULT	PubMed
26773077	BACKGROUND	PubMed
30755171	DERIVED	PubMed

1 to 10 of 12

See all 12 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov: 2026-11-12; ClinicalTrials.gov
Results, from AACT: 2026-03-23; AACT
NIH grant links: 2026-11-13; NIH RePORTER

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02982668

GET https://conductscience.org/api/trials/v1/NCT02982668/registered

API reference For AI assistants